- Home
- PERF vs NKTX Comparison
PERF vs NKTX Comparison
Compare PERF & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERF
- NKTX
- Stock Information
- Founded
- PERF 2015
- NKTX 2015
- Country
- PERF Taiwan
- NKTX United States
- Employees
- PERF N/A
- NKTX N/A
- Industry
- PERF Computer Software: Prepackaged Software
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- PERF Technology
- NKTX Health Care
- Exchange
- PERF Nasdaq
- NKTX Nasdaq
- Market Cap
- PERF 166.0M
- NKTX 170.8M
- IPO Year
- PERF N/A
- NKTX 2020
- Fundamental
- Price
- PERF $1.60
- NKTX $1.71
- Analyst Decision
- PERF Buy
- NKTX Strong Buy
- Analyst Count
- PERF 1
- NKTX 6
- Target Price
- PERF $5.00
- NKTX $15.00
- AVG Volume (30 Days)
- PERF 83.3K
- NKTX 2.5M
- Earning Date
- PERF 04-28-2025
- NKTX 05-08-2025
- Dividend Yield
- PERF N/A
- NKTX N/A
- EPS Growth
- PERF 7.43
- NKTX N/A
- EPS
- PERF 0.05
- NKTX N/A
- Revenue
- PERF $60,202,000.00
- NKTX N/A
- Revenue This Year
- PERF $16.02
- NKTX N/A
- Revenue Next Year
- PERF $14.43
- NKTX N/A
- P/E Ratio
- PERF $33.88
- NKTX N/A
- Revenue Growth
- PERF 12.52
- NKTX N/A
- 52 Week Low
- PERF $1.55
- NKTX $1.31
- 52 Week High
- PERF $3.44
- NKTX $9.09
- Technical
- Relative Strength Index (RSI)
- PERF 43.99
- NKTX 50.12
- Support Level
- PERF $1.56
- NKTX $1.42
- Resistance Level
- PERF $1.72
- NKTX $1.99
- Average True Range (ATR)
- PERF 0.12
- NKTX 0.19
- MACD
- PERF 0.01
- NKTX 0.01
- Stochastic Oscillator
- PERF 40.62
- NKTX 30.98
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.